Production Method 1

75-21-8

4165-57-5

912627-99-7

Reaction Conditions

1.1R:Mg, C:I2, S:THF, reflux; 4 h, reflux; reflux → 0°C
1.2S:THF, 0°C; 0°C → rt; overnight, rt
1.3R:HCl, S:H2O, 0°C
2.1R:Et3N, S:CH2Cl2, 4 h, 0°C
3.1R:NaN3, S:DMF, rt → 70°C; overnight, 70°C
3.2S:H2O, cooled
4.1R:LiAlH4, S:Et2O, rt; 3 h, reflux; overnight, rt

Reference

The synthesis of [phenyl-2H5]gluconasturtiin and its metabolites for metabolic studies

By Morrison, John J. and Botting, Nigel P., Journal of Labelled Compounds & Radiopharmaceuticals, 2005, 48(12), 897-907

Production Method 2

912627-99-7

Reaction Conditions

1.1R:CF3SO3D, cooled; 1 h, rt; cooled
1.2R:D2O
1.3R:NaOH, S:D2O, pH 11

Reference

Mild and selective hydrogen-deuterium exchange for aromatic hydrogen of amines

By Tachrim, Zetryana Puteri et al, Journal of Labelled Compounds and Radiopharmaceuticals, 2023, 66(10), 321-331

Production Method 3

284664-89-7

912627-99-7

Reaction Conditions

1.1R:Isocyanuric chloride, R:C5H5N, S:MeOH, 30 min, rt
2.1R:ZrCl4, R:NaBH4, S:THF, 5 h, rt
2.2R:NH4OH, basify

Reference

Synthesis of stable isotope-labeled nasturlexins and potential precursors to probe biosynthetic pathways of cruciferous phytoalexins

By Pedras, M. Soledade C. and To, Q. Huy, Journal of Labelled Compounds and Radiopharmaceuticals, 2018, 61(2), 94-106

2-PHENYL-D5-ETHYLAMINE Raw materials

• DL-Phenylalanine-d
• Ethylene Oxide
• Bromobenzene-d5

2-PHENYL-D5-ETHYLAMINE Preparation Products

• 2-PHENYL-D5-ETHYLAMINE (912627-99-7)

• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. Aggregation-induced chiral symmetry breaking of a naphthalimide–cyanostilbene dyad?
  Xin Li,Liangliang Zhu,Sai Duan,Yanli Zhao,Hans ?gren Phys. Chem. Chem. Phys., 2014,16, 23854-23860
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)